Gulam A. Manji, MD, PhD | Authors


Identification of Actionable Mutations Remains an Unmet Need in CRC

September 26, 2019

Gulam A. Manji, MD, PhD, discusses the need to identify mutations that may be actionable in patients with colorectal cancer. The identification of such mutations can further impact patient survival and improve efficacy, says Manji, in both CRC and other gastrointestinal cancers.